Skip to main content
# Title Department Research Year
91 Design and synthesis of New dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition Department of Pharmaceutical Organic Chemistry 2024
92 Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists. Department of Pharmaceutical Organic Chemistry 2024
93 Development of Oral Formulation of Lepidium Seeds Significantly Decreases the High Blood Glucose Levels in Diabetic Rats; In Vitro Formulation and In Vivo Antidiabetic Performance. Department of Industrial Pharmacy 2024
94 Levetiracetam sandwich-type electrochemical sensor based on bimetallic MXenes nanoflakes/DNA/vertically oriented graphene oxide doped with cobalt nanocomposites Department of Pharmaceutical Analytical Chemistry 2024
95 Synthesis, enzyme inhibition, and docking studies of new Schiff bases of disalicylic acid methylene-based derivatives as dual-target antibacterial agents Department of Pharmaceutical Organic Chemistry 2024
96 Dual emission BSA-capped bimetallic nanoclusters for detection of acrylamide in certain food matrices based on thiol-ene Michael addition click reaction Department of Pharmaceutical Analytical Chemistry 2024
97 Thunbergiside A: An unprecedented neolignan isolated from Gardenia thunbergia L. f. and the antifungal activity of selected phytochemicals Department of Pharmacognosy 2024
98 Developing a switch “OFF-ON” fluorescent probe for detection of melamine based on doubly-protected red emissive copper nanoclusters mediated by Hg2+ ions Department of Pharmaceutical Analytical Chemistry 2024
99 Finding new analgesics: Computational pharmacology faces drug discovery challenges Department of Pharmacology 2024
100 Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and Topoisomerase IV inhibitors endowed with antibacterial properties Department of Pharmaceutical Organic Chemistry 2024